Cytotoxic T-lymphocyte responses to cytomegalovirus in normal and simian immunodeficiency virus-infected rhesus macaques

Journal of Virology

Volumn 70, Issue 11, 1996, Pages 7725-7733

  Kaur, Amitinder ^a,b   Daniel, Muthiah D ^a   Hempel, Donna ^a   Lee Parritz, David ^a   Hirsch, Martin S ^b   Johnson, R Paul ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN ANTIBODY COMPLEX; ANTIGEN RECOGNITION; ARTICLE; CYTOTOXIC T LYMPHOCYTE; IMMUNOPATHOLOGY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN ANALYSIS; RHESUS MONKEY; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS ISOLATION;

EID: 0029817239     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.11.7725-7733.1996     Document Type: Article

References (48)

1. Asher, D. M., C. J. Gibbs, Jr., D. J. Lang, and D. C. Gajdusek. 1974. Persistent shedding of cytomegalovirus in the urine of healthy monkeys (37897). Proc. Soc. Exp. Biol. Med. 145:794-801.
2. Barry, P. A., E. Pratt-Lowe, D. J. Alcendor, R. E. Unger, and P. A. Luciw. 1990. Molecular interactions between human immunodeficiency virus type 1 and human cytomegalovirus. Ann. N. Y. Acad. Sci. 616:54-63.
3. Barry, P. A., E. Pratt-Lowe, R. E. Unger, M. Marthas, D. J. Alcendor, and P. A. Luciw. 1990. Molecular interactions of cytomegalovirus and the human and simian immunodeficiency viruses. J. Med. Primatol. 19:327-337.
4. Baskin, G. B. 1987. Disseminated cytomegalovirus infection in immunodeficient rhesus monkeys. Am. J. Pathol. 129:345-352.
5. Baskin, G. B., M. Murphey-Corb, E. A. Watcon, and L. N. Martin. 1988. Necropsy findings in rhesus monkeys experimentally infected with cultured simian immunodeficiency virus (SIV)/Delta. Vet. Pathol 25:456-467.
6. Borysiewicz, L. K., S. Morris, J. D. Page, and J. G. P. Sissons. 1983. Human cytomegalovirus-specific cytotoxic lymphocytes: requirements for in vitro generation and specificity. Eur. J. Immunol. 13:804-809.
7. Clerici, M., N. I. Stocks, R. A. Zajac, R. N. Boswell, D. R. Lucey, C. S. Via, and G. M. Shearer. 1989. Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. J. Clin. Invest. 84:1892-1899.
8. + individuals. Clin. Exp. Immunol. 82:559-566.
9. Del Va, M., H.-J. Schlicht, H. Volkmer, M. Messerle, M. J. Reddehase, and U. H. Koszinowski. 1991. Protection against lethal cytomegalovirus infection by a recombinant vaccine containing a single nonameric T-cell epitope. J. Virol. 65:3641-3646.
10. Dobrescu, D., B. Ursea, M. Pope, A. S. Asch, and D. N. Posnett. 1995. Enhanced HIV-1 replication in Vβ12 T cells due to human cytomegalovirus in monocytes: Evidence for a putative herpesvirus superantigen. Cell 82:753-763.
11. Fiala, M., J. D. Mosca, P. Barry, P. A. Luciw, and H. V. Vinters. 1991. Multi-step pathogenesis of AIDS - role of cytomegalovirus. Res. Immunol. 142:87-95.
12. Flo, R. W., G. Haukenes, A. Nilsen, R. Skjaerven, M. Forsgren, and T. E. Fehniger. 1995. Longitudinal study of cytomegalovirus antibodies in individuals infected with the human immunodeficiency virus. Eur. J. Clin. Microbiol. Infect. Dis. 14:504-511.
13. Griffiths, P. D., and J. E. Grundy. 1987. Molecular biology and immunology of cytomegalovirus. Biochem. J. 241:313-324.
14. Hanson, C. V., J. L. Riggs, and L. E.H. 1978. Photochemical inactivation of DNA and RNA viruses by psoralen derivatives. J. Gen. Virol. 40:345-358.
15. Hirsch, M. S. 1994. Herpes group virus infections in the compromised host, p. 379-396. In R. H. Rubin and L. S. Young (ed.), Clinical approach to infection in the compromised host. Plenum, New York.
16. Ho, W.-Z., V. Ayyavoo, A. Srinivasan, M. F. Stinski, S. A. Plotkin, and E. Gonczol. 1991. Human immunodeficiency virus type 1 tat gene enhances human cytomegalovirus gene expression and viral replication. AIDS Res. Hum. Retroviruses 7:689-695.
17. Jahn, G., and M. Mach. 1990. Human cytomegalovirus phosphoproteins and glycoproteins and their coding regions. Curr. Top. Microhiol. Immunol. 154:171-185.
18. Johnson, V. A., and R. E. Byington. 1990. Quantitative assays for virus infectivity: infectivity assay (virus yield assay), p. 71-76. In A. Aldovini and B. D. Walker (ed.), Techniques in HIV research. Stockton Press, New York.
19. Jonjic, S., M. Del Val, G. M. Keil, M. J. Reddehase, and U. H. Koszinowski. 1988. A nonstructural viral protein expressed by a recombinant vaccinia virus protects against lethel cytomegalovirus infection. J. Virol. 62:1653-1658.
20. Jonjic, S., I. Pavic, B. Polic, I. Crnkovic, P. Lucin, and U. H. Koszinowski. 1994. Antibodies are not essential for the resolution of primary cytomegalovirus infection but limit dissemination of recurrent virus. J. Exp. Med. 179:1713-1717.
21. Lackner, A. A. 1994. Pathology of simian immunodeficiency virus induced disease. Curr. Top. Microbiol. Immunol. 188:35-64.
22. Li, C.-R., P. D. Greenberg, M. J. Gilbert, J. M. Goodrich, and S. R. Riddell. 1994. Recovery of HLA-restricted cytomegalovirus (CMV)-specific T-cell responses after allogeneic bone marrow transplant: correlation with CMV disease and effect of ganciclovir prophylaxis. Blood 83:1971-1979.
23. Manion, D. J., and M. S. Hirsch. 1994. Bidirectional interactions between human immunodeficiency virus and cytomegalovirus, p. 45-64. In H. J. Kung and C. Wood (ed.). Interactions between retroviruses and herpesviruses. World Scientific, Singapore.
24. Margalith, M., R. T. D'Aquila, D. J. Manion, N. Basgoz, L. J. Bechtel, B. R. Smith, J. C. Kaplan, and M. S. Hirsch. 1995. HIV-1 DNA in fibroblast cultures infected with urine from HIV-seropositive cytomegalovirus (CMV) excretors. Arch. Virol. 140:927-935.
25. McLaughlin-Taylor, E., H. Pande, S. J. Forman, B. Tanamachi, C.-R. Li, J. A. Zaia, P. D. Greenberg, and S. R. Riddell. 1994. Identification of the major late human cytomegalovirus matrix protein pp65 as a target antigen for CD8+ virus-specific cytotoxic T lymphocytes. J. Med. Virol. 43:103-110.
26. Nuchtern, J. G., J. S. Bonifacino, W. E. Biddison, and R. D. Klausner. 1989. Brefeldin A implicates egress from endoplasmic reticulum in class I restricted antigen presentation. Nature (London) 339:223-226.
27. Ohtaki, S., H. Kodama, R. Hondo, and T. Kurata. 1986. Activation of cytomegalovirus infection in immunosuppressed cynomolgus monkeys inoculated with varicella-zoster virus. Acta Pathol. Jpn. 36:1537-1552.
28. Osborn, K. G., S. Prahalada, L. J. Lowenstine, M. B. Gardner, D. H. Maul, and R. V. Henrickson. 1984. The pathology of an epizootic of acquired immunodeficiency in rhesus macaques. Am. J. Pathol. 114:94-103.
29. Quinnan, G. V., Jr., W. H. Burns, N. Kirmani, A. H. Rook, J. Manischewitz, L. Jackson, G. W. Santos, and R. Saral. 1984. HLA-restricted cytotoxic T lymphocytes are an early immune response and important defense mechashy; nism in cytomegalovirus infections. Rev. Infect. Dis. 6:156-163.
30. Reddehase, M. J., W. Mutter, K. Munch, H.-J. Buhring, and U. H. Koszinowski. 1987. CD8-positive T lymphocytes specific for murine cytomegalovirus immediate-early antigens mediate protective immunity. J. Virol. 61: 3102-3108.
31. Reusser, P., S. R. Riddell, J. D. Meyers, and P. D. Greenberg. 1991. Cytotoxic T-lymphocyte responses to cytomegalovirus after human allogeneic bone marrow transplantation: pattern of recovery and correlation with cytomegalovirus infection and disease. Blood 78:1373-1380.
32. Riddell, S. R., and P. D. Greenberg. 1994. Therapeutic reconstitution of human viral immunity by adoptive transfer of cytotoxic T lymphocyte clones. Curr. Top. Microbiol. Immunol. 189:9-34.
33. Riddell, S. R., M. Rabin, A. P. Geballe, W. J. Britt, and P. D. Greenberg. 1991. Class I MHC-restricted cytotoxic T lymphocyte recognition of cells infected with human cytomegalovirus does not require endogenous viral gene expression. J. Immunol. 146:2795-2804.
34. Riddell, S. R., B. A. Walter, M. J. Gilbert, and P. D. Greenberg. 1994. Selective reconstitution of CD8+ cytoxic T lymphocyte responses in immunodeficient hone marrow transplant recipients by the adoptive transfer of T cell clones. Bone Marrow Transplant. 14:S78-S84.
35. Rook, A. H., J. F. Manischewitz, W. R. Frederick, J. S. Epstein, L. Jackson, E. Gelmann, R. Steis, H. Masur, and G. V. Quinnan, Jr. 1985. Deficient, HLA-restricted, cytomegalovirus-specific cytotoxic T cells and natural killer cells in patients with the acquired immunodeficiency syndrome. J. Infect. Dis. 152:627-630.
36. Rook, A. H., G. V. Quinnan, Jr., W. J. R. Frederick, J. F. Manischewitz, N. Kirmani, T. Dantzler, B. B. Lee, and C. B. Currier, Jr. 1984. Importance of cytotoxic lymphocytes during cytomegalovirus infection in renal transplant recipients. Am. J. Med. 76:385-392.
37. Schrier, R. D., W. R. Freeman, C. A. Wiley, J. A. McCutcham, and T. H. group. 1995. Immune predispositions for cytomegalovirus retinitis in AIDS. J. Clin. Invest. 95:1741-1746.
38. Simon, M. A., L. V. Chalifoux, and D. J. Ringler. 1992. Pathologic features of SIV-induced disease and the association of macrophage infection with disease evolution. AIDS Res. Hum. Retroviruses 8:327-337.
39. Skolnik, P. R., B. R. Kosloff, and M. S. Hirsch. 1988. Bidirectional interactions between human immunodeficiency virus type I and cytomegalovirus. J. Infect. Dis. 157:508-514.
40. Spaete, R. R., R. C. Gehrz, and M. P. Landini. 1994. Human cytomegalovirus structural proteins. J. Gen. Virol. 75:3287-3308.
41. Swack, N. S., and G. D. Hsiung. 1982. Natural and experimental simian cytomegalovirus infections at a primate center. J. Med. Primatol. 11:169-177.
42. Swack, N. S., O. C. Liu, and G. D. Hsiung. 1971. Cytomegalovirus infections of monkeys and baboons. Am. J. Epidemiol. 94:397-402.
43. Vogel, P., B. J. Weigler, H. Kerr, A. G. Hendrickx, and P. A. Barry. 1994. Seroepidemiologic studies of cytomegalovirus infection in a breeding population of rhesus macaques. Lab. Anim. Sci. 44:25-30.
44. Walter, E. A., P. D. Greenberg, M. J. Gilbert, R. J. Finch, K. S. Watanabe, E. D. Thomas, and S. R. Riddell. 1995. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic hone marrow by transfer of T-cell clones from the donor. N. Engl. J. Med. 333:1038-1044.
45. Watkins, D. I., M. Kannagi, M. E. Slone, and N. L. Letvin. 1988. Major histocompatibility complex class I molecules of nonhuman primates. Eur. J. Immunol. 18:1425-1432.
46. Wyand, M. S., K. H. Manson, M. Garcia-Moll, D. Montefiori, and R. C. Desrosiers. 1996. Vaccine protection by a triple deletion of simian immunodeficiency virus. J. Virol. 70:3724-3733.
47. Yang, S. Y. 1989. A standardized method for detection of HLA-A and HLA-B alleles by one-dimensional isoelectric focusing (IEF) gel electrophoresis, p. 332-335. In B. Dupont (ed.). Immunobiology of HLA. Springer-Verlag, New York.
48. Yewdell, J. W., and J. R. Bennink. 1989. Brefeldin A specifically inhibits presentation of protein antigens to cytotoxic T lymphocytes. Science 244: 1072-1075.